Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer

Published on :

Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer Descartes-11 specifically designed to integrate into standard treatment regimen for newly diagnosed multiple myeloma without [….]

How mRNA-based Vaccines Have Changed the Vaccine Game

Published on :

With the unprecedented speed of vaccine development amid the COVID-19 pandemic, questions have emerged regarding the future of vaccinology beyond the coronavirus. In a panel on vaccinology in the 21st century hosted by Noble Life Sciences, scientists discussed the vaccine platforms available to us now, the significance of mRNA vaccines and the emergence of new combination vaccines.